Fiduciary Trust CO Vertex Pharmaceuticals Inc Transaction History

Fiduciary Trust CO

$6.5 Billion
Q2 2024

A detailed history of Fiduciary Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fiduciary Trust CO holds 9,830 shares of VRTX stock, worth $4.66 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

9,830

Previous 8,621 14.02%

Holding current value

$4.66 Million

Previous $3.6 Million 27.87%

% of portfolio

0.07%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $474,907 - $587,005	1,209 Added 14.02%	9,830 $4.61 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $558,127 - $610,683	1,369 Added 18.88%	8,621 $3.6 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $875,679 - $1.05 Million	2,553 Added 54.33%	7,252 $2.95 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $50,388 - $54,006	149 Added 3.27%	4,699 $1.63 Million
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $83,006 - $92,904	264 Added 6.16%	4,550 $1.6 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $45,316 - $51,696	-160 Reduced 3.6%	4,286 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $94,586 - $106,409	331 Added 8.04%	4,446 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $188,668 - $210,510	689 Added 20.11%	4,115 $1.19 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $51,456 - $64,068	219 Added 6.83%	3,426 $966,000
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $710,093 - $836,930	3,207 New	3,207 $837,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $505,894 - $638,620	-2,858 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $11,790 - $13,194	-65 Reduced 2.22%	2,858 $519,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $60,371 - $71,194	-322 Reduced 9.92%	2,923 $590,000
Q1 2021 May 19, 2021	BUY	$207.02 - $241.31 $242,627 - $282,815	1,172 Added 56.54%	3,245 $697,000
Q4 2020 Jan 26, 2021	BUY	$207.01 - $276.09 $429,131 - $572,334	2,073 New	2,073 $490,000
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $387,814 - $436,480	-2,333 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $197,532 - $228,444	1,200 Added 105.91%	2,333 $428,000
Q1 2019 May 07, 2019	BUY	$163.73 - $194.7 $185,506 - $220,595	1,133 New	1,133 $209,000
Q4 2018 Jan 29, 2019	SELL	$151.91 - $192.21 $176,519 - $223,348	-1,162 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $194,902 - $223,963	1,162 New	1,162 $224,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Vertex Pharmaceuticals Inc Transaction History